Literature DB >> 17666980

Quality of life for men with prostate cancer.

Anne Katz1.   

Abstract

The aim of this article is to selectively review the current research findings related to quality of life and prostate cancer. English-language journals indexed in MEDLINE, PubMed, and CINAHL published between 1999 and 2005 were searched for relevant articles using the following keywords: "quality of life and prostate cancer," "prostatectomy," "radiation therapy," "brachytherapy," "cryotherapy," or "androgen deprivation therapy." References in selected articles were reviewed for potentially relevant articles not identified through database searches. All treatment modalities have a significant impact on quality of life for men with local or advanced prostate cancer. Alterations in sexual functioning cause the most significant impact on quality of life for men. Quality of life is decreased in both the short and long term for men with prostate cancer. Oncology nurses must be cognizant of the challenges that a diagnosis of prostate cancer presents to the man with prostate cancer and his partner. Patients should be fully informed of the potential for impact on quality of life with all treatment modalities, and the oncology nurse can play an important role in both providing this information and supporting the patient when quality of life is impacted.

Entities:  

Mesh:

Year:  2007        PMID: 17666980     DOI: 10.1097/01.NCC.0000281726.87490.f2

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  16 in total

1.  Evidence-based guideline recommendations on low-dose rate brachytherapy in patients with low- or intermediate-risk prostate cancer.

Authors:  George Rodrigues; Xiaomei Yao; D Andrew Loblaw; Michael Brundage; Joseph L Chin
Journal:  Can Urol Assoc J       Date:  2013 May-Jun       Impact factor: 1.862

2.  A pilot study of potential pre-operative barriers to couples' sexual recovery after radical prostatectomy for prostate cancer.

Authors:  Daniela Wittmann; Laurel Northouse; Heather Crossley; David Miller; Rodney Dunn; Jennifer Nidetz; Jeanne Montie; Mia Moyad; Katie Lavin; James E Montie
Journal:  J Sex Marital Ther       Date:  2014-01-09

3.  Health-related quality of life following radical prostatectomy: long-term outcomes.

Authors:  Andrew G Matthew; Shabbir M H Alibhai; Tal Davidson; Kristen L Currie; Haiyan Jiang; Murray Krahn; Neil E Fleshner; Robin Kalnin; Alyssa S Louis; B Joyce Davison; John Trachtenberg
Journal:  Qual Life Res       Date:  2014-03-09       Impact factor: 4.147

Review 4.  Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review.

Authors:  George Rodrigues; Xiaomei Yao; D Andrew Loblaw; Michael Brundage; Joseph L Chin
Journal:  Can Urol Assoc J       Date:  2013-11       Impact factor: 1.862

Review 5.  Comparison of prostate-specific membrane antigen ligands in clinical translation research for diagnosis of prostate cancer.

Authors:  Sagnik Sengupta; Mena Asha Krishnan; Sudeshna Chattopadhyay; Venkatesh Chelvam
Journal:  Cancer Rep (Hoboken)       Date:  2019-04-02

6.  The Prostate Cancer Rehabilitation Clinic: a biopsychosocial clinic for sexual dysfunction after radical prostatectomy.

Authors:  A Matthew; N Lutzky-Cohen; L Jamnicky; K Currie; A Gentile; D Santa Mina; N Fleshner; A Finelli; R Hamilton; G Kulkarni; M Jewett; A Zlotta; J Trachtenberg; Z Yang; D Elterman
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

7.  Health-related quality of life of Chinese patients with prostate cancer in comparison to general population and other cancer populations.

Authors:  Edmond P H Choi; Carlos K H Wong; James H L Tsu; W Y Chin; Kenny Kung; Charles K W Wong; M K Yiu
Journal:  Support Care Cancer       Date:  2015-10-09       Impact factor: 3.603

8.  Millon Behavioral Medicine Diagnostic (MBMD) Predicts Health-Related Quality of Life (HrQoL) over time among men treated for localized prostate cancer.

Authors:  Dean G Cruess; Catherine Benedict; Emily G Lattie; Ivan Molton; Dave Kinsinger; Bruce Kava; Murugesan Manoharan; Mark Soloway; Frank J Penedo
Journal:  J Pers Assess       Date:  2012-05-09

9.  Psychological Distress among Prostate Cancer Patients: Fact Or Fiction?

Authors:  Christopher F Sharpley; Vicki Bitsika; David H R Christie
Journal:  Clin Med Oncol       Date:  2008-12-16

10.  The antioxidant, MnTE-2-PyP, prevents side-effects incurred by prostate cancer irradiation.

Authors:  Rebecca E Oberley-Deegan; Joshua J Steffan; Kyle O Rove; Kathryn M Pate; Michael W Weaver; Ivan Spasojevic; Barbara Frederick; David Raben; Randall B Meacham; James D Crapo; Hari K Koul
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.